LABS.TO

MediPharm Labs Corp. LABS.TO

LABS.TO
MediPharm Labs Corp. CWEB.TO
Charlotte's Web Holdings, Inc. ROMJ.V
Rubicon Organics Inc. AVCN.TO
Avicanna Inc. GLAB.CN
Gemina Laboratories Ltd. GWAY.CN
Greenway Greenhouse Cannabis Corporation BUX.CN
BioMark Diagnostics Inc. RVX.TO
Resverlogix Corp. VM.V
Voyageur Pharmaceuticals Ltd. ADK.V
DIAGNOS Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode LABS.TO CWEB.TO ROMJ.V AVCN.TO GLAB.CN GWAY.CN BUX.CN RVX.TO VM.V ADK.V
6M -11.76 % 108.33 % 16.67 % 16.67 % -60.87 % -2.50 % 32.00 % 144.44 % -25.00 % 52.00 %
YTD 15.38 % 72.41 % 16.67 % -12.50 % -43.04 % -42.65 % 65.00 % 120.00 % 50.00 % 26.67 %
1Y 0.00 % 42.86 % 41.77 % 0.00 % 28.57 % -44.29 % 34.69 % 83.33 % 92.86 % 13.43 %
3Y 7.14 % -77.27 % -27.27 % -6.67 % -8.16 % -62.50 % 69.23 % -42.11 % 50.00 % 123.53 %
5Y -91.76 % -94.08 % -86.24 % -70.83 % 26.76 % -62.50 % 94.12 % -90.83 % 200.00 % -35.59 %
10Y -97.63 % -98.27 % -82.77 % -95.51 % 26.76 % -62.50 % 153.85 % -93.29 % 35.00 % -24.00 %
From the beginning -97.63 % -98.27 % -82.77 % -95.51 % 26.76 % -62.50 % -25.00 % -95.30 % 35.00 % -99.51 %

Dividend